EMCDDA news

Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day to increase awareness and understanding of viral hepatitis and the diseases it causes. The day unites patient organisations, governments, medical professionals, civil society, industry and the general public to boost the global profile of viral hepatitis. This year, the WHO will focus on the theme: ‘Test. Treat. Hepatitis’ affirming that timely testing and treatment of viral hepatitis B and C can save lives. 27.07.2018

EMCDDA Director Alexis Goosdeel today visited his new counterpart at Europol, Ms Catherine De Bolle in the first official meeting between the two heads of agencies. 17.07.2018

EMCDDA news

World Hepatitis Day 2018

Systematic review on the prevention and control of blood-borne viruses in prison settings

Alexis Goosdeel meets new Executive Director of Europol

Report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) in the framework of the Council Decision on new psychoactive substances

Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council Decision on new psychoactive substances

Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF) in the framework of the Council Decision on new psychoactive substances

Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA) in the framework of the Council Decision on new psychoactive substances

Report on the risk assessment of N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) in the framework of the Council Decision on new psychoactive substances

Annual accounts 2017

Map of Aid

EMCDDA news

Call to action on drug-related violence — #BreakTheCycle